⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ATYR News
aTyr Pharma, Inc. Common Stock
Pomerantz LLP Issues Reminder to Shareholders in aTyr Pharma, Inc. of Class Action – ATYR
accessnewswire.com
ATYR
ATYR STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that aTyr Pharma, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
accessnewswire.com
ATYR
Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) Shareholders of Class Action Lawsuit and December 8, 2025 Deadline
accessnewswire.com
ATYR
Levi & Korsinsky Notifies aTyr Pharma, Inc. (ATYR) Shareholders of Class Action Lawsuit and December 8, 2025 Deadline
accessnewswire.com
ATYR
Levi & Korsinsky Urges aTyr (ATYR) Shareholders to Act Before Lead Plaintiff Deadline December 8, 2025
accessnewswire.com
ATYR
aTyr Pharma, Inc. (ATYR) Failed Drug Trial Spurs Securities Lawsuit; Class Period Significantly Enlarged - Hagens Berman
accessnewswire.com
ATYR
Shareholders of aTyr Pharma, Inc. (ATYR): Protect Your Rights Before December 8, 2025 - Contact Levi & Korsinsky
accessnewswire.com
ATYR
SueWallSt Podcast Explains Class Action Against aTyr Pharma, Inc. (ATYR)
accessnewswire.com
ATYR
Class Action Lawsuit Filed Against aTyr Pharma, Inc. (ATYR) - Recover Losses - Contact Levi & Korsinsky Before December 8, 2025
accessnewswire.com
ATYR
Pomerantz LLP Issues Reminder to Investors in aTyr Pharma, Inc. of Class Action Lawsuit – ATYR
accessnewswire.com
ATYR